Addressing the epidemic: pharmacotherapeutic management of diabetes in women.
Diabetes is epidemic in the United States. More than half of the victims are women, and women from vulnerable populations have particularly high rates of diabetes. In addition, long-term complications of diabetes are contributing factors to poverty, disability, and premature death, and complications of diabetes are more common and more serious in women. The provision of health care to women with diabetes must include knowledge of the pharmacotherapeutic agents used to treat diabetes to provide care that compliments and does not complicate diabetes management.
Reedy
Nancy Jo
NJ
Nurse-Midwifery Services, Texas Health Care, Fort Worth, USA.
D001645:Biguanides / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007328:Insulin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008880:Midwifery / Q000379:methods; D010880:Piperidines / Q000627:therapeutic use; D011247:Pregnancy; D012307:Risk Factors; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
D001645:Biguanides; D002219:Carbamates; D007004:Hypoglycemic Agents; D007328:Insulin; D010880:Piperidines; D013453:Sulfonylurea Compounds